Bioscience
Building Arizona as a global center for research and commercialization in the biosciences.
Connect with Flinn Bioscience: Stay up to date. Join our email list.
Bioscience in Arizona
The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector through 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
Arizona’s Bioscience Roadmap Progress Report set for April 19
The Flinn Foundation will host an online event from noon to 1:30 p.m. April 19 to provide its annual update on the progress of Arizona’s bioscience sector.
Arizona’s Bioscience Roadmap, which is entering its third decade as the state’s long-term strategic plan, has guided the growth and progress of the biosciences since 2002. The Roadmap was updated in 2014 with the goal of Arizona becoming globally competitive and a national leader in select areas of the biosciences by 2025. [Register]
Dr. David Gullen to hand over Flinn Foundation board chair after more than two decades of service
Dr. David Gullen, the longest-serving member of the Flinn Foundation board of directors, is stepping down as chair after 21 years of leading the philanthropic grantmaking organization. He will remain a board member through March 2024 before retiring.
Dr. Eric Reiman, who joined the Flinn board in 1999 and has served as secretary since 2008, has been elected as its new chair. Reiman, a psychiatrist and brain-imaging researcher by background, is nationally recognized for his contributions to the study, unusually early detection, and prevention of Alzheimer’s disease. [Read more]
On the rise in 2023: Six Arizona bioscience startups
The six Arizona bioscience startups competitively selected to represent the 2023 Flinn Foundation Bioscience Entrepreneurship Program are Delta Development Team of Tucson, EMR Data Cloud of Scottsdale, Reference Medicine of Phoenix, Televeda of Phoenix, The Patient Company of Scottsdale, and TheraCea Pharma of Tucson.
Over the next year, the program participants will receive $30,000 in funding support, administered by the Arizona Bioindustry Association, a personalized learning plan, and invitations to exclusive gatherings of Arizona bioscience and policy leaders as well as convenings with fellow entrepreneurs. [Read more]
Translational seed grants program to fund 10 projects
In 2023, the Flinn Foundation Seed Grants to Promote Translational Research Program will fund up to 10 research teams affiliated with an Arizona university, research institution, or health-care system that are advancing new products or services to improve patient care.
Awardees will each receive a $100,000 grant over 18 months, plus programmatic benefits, with each team using the grant period to de-risk its product/process, refine its design, and/or acquire key validation data and stakeholder feedback. The 2023 awardees will be announced in June. [Read More]
Two decades of success as Arizona’s Bioscience Roadmap turns 20
Arizona’s Bioscience Roadmap was officially launched by the Flinn Foundation in a crowded ballroom at the Arizona Biltmore on Dec. 3, 2002. A public commitment to fund the biosciences for 10 years was made by the foundation—and later extended through 2025—including the commission of an independent study that led to the long-term strategic plan.
We as Arizonans celebrate the triumphs of the past 20 years and thank the people whose work and dedication have made Arizona’s Bioscience Roadmap a success. [Read more]
News and Updates
Bioscience
Arizona Bioscience News: GT Medical Technologies raises $45M; Tucson economic expansion; Startups join MedTech accelerator
Tempe medical device firm raises $45M to expand technology to treat brain tumors / Phoenix Business Journal (AZ Inno) Tempe-based GT Medical Technologies Inc. raised $45 million that will be used to expand the company’s commercialization of its GammaTile Therapy, a targeted radiation therapy with U.S. Food and Drug Administration clearance for patients with operable brain […]
Bioscience
Dr. David Gullen to hand over Flinn Foundation board chair after more than two decades of service
Dr. Eric Reiman, nationally recognized Alzheimer’s researcher, selected as new chair Dr. David Gullen, the longest-serving member of the Flinn Foundation board of directors, is stepping down as chair after 21 years of leading the philanthropic grantmaking organization. He will remain a board member through March 2024 before retiring. Gullen, a physician who practiced internal […]
Bioscience
Arizona Bioscience News: Banner Health in Scottsdale; HonorHealth radiation study; Final four startups
Banner to build $400 million hospital, cancer center in north Scottsdale / Arizona Republic Banner Health is planning to build a $400 million hospital and cancer center in north Scottsdale on 48 acres off Loop 101—the four-story Banner Scottsdale Medical Center that is expected to open in 2026 with 106 patient beds. Read more: Banner Health to build […]
Bioscience
Arizona Bioscience News: $90M to ASU for X-ray science; Barrow’s FTD study; Valley fever cases
National Science Foundation awards $90.8M to ASU to advance X-ray science / ASU News Arizona State University will receive $90.8 million from the National Science Foundation to support a five-year project to build the world’s first Compact X-ray Free Electron Laser, or CXFEL, that will help scientists observe biology’s molecular processes in detail—processes that are important […]
For information about Bioscience, please contact:
bioscience@flinn.org or (602) 744-6831
Bradley W. Halvorsen
Executive Vice President
Mary O’Reilly, Ph.D.
Vice President, Bioscience Research Programs
Juliet Gomez
Program Manager
Julie Anderson
Grants Coordinator